|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) including noncontrolling interests | |||||
| Adjustments to reconcile net income (loss) to net cash from operating activities: | |||||
| Depreciation and amortization | |||||
| Non-cash impairment and other charges | |||||
| Share-based compensation expenses related to equity classified awards | |||||
| Non-cash restructuring and other related charges | |||||
| Amortization and write-offs of program rights | |||||
| Amortization of deferred carriage fees | |||||
| Unrealized foreign currency transaction (gain) loss | |||||
| Amortization of deferred financing costs and discounts on indebtedness | |||||
| Bad debt expense | |||||
| Deferred income taxes | |||||
| Gains on investments | |||||
| Other, net | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable, trade (including amounts due from related parties, net) | |||||
| Prepaid expenses and other assets | |||||
| Program rights and obligations, net | |||||
| Income taxes payable | |||||
| Deferred revenue | |||||
| Deferred carriage fees, net | |||||
| Accounts payable, accrued liabilities and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expenditures | |||||
| Return of capital from investees | |||||
| Acquisition of investments | |||||
| Loans to investees | |||||
| Cash paid on distribution of business | |||||
| Principal payments received on loans to investees | |||||
| Payments for acquisitions of businesses, net of cash acquired | |||||
| Proceeds from sale of investments | |||||
| Other, net | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from the issuance of long-term debt | |||||
| Proceeds from issuance of Senior Secured Notes, net | |||||
| Proceeds from the issuance of 4.25% Convertible Senior Notes due 2029, net | |||||
| Principal payments on Term Loan A Facility | |||||
| Payments for financing costs | |||||
| Principal payments on long-term debt | |||||
| Deemed repurchases of restricted stock units | |||||
| Proceeds from stock option exercises | |||||
| Purchase of treasury stock | |||||
| Principal payments on finance lease obligations | |||||
| Purchase of noncontrolling interests | |||||
| Contributions from noncontrolling interests | |||||
| Distributions to noncontrolling interests | |||||
| Net cash used in financing activities | |||||
| Net increase (decrease) in cash and cash equivalents from operations | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
Loading...